Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies

被引:96
作者
Hotez, Peter J. [1 ,2 ]
Pecoul, Bernard [3 ]
Rijal, Suman [4 ]
Boehme, Catharina [5 ]
Aksoy, Serap [6 ]
Malecela, Mwelecele [7 ]
Tapia-Conyer, Roberto [8 ]
Reeder, John C. [9 ]
机构
[1] Baylor Coll Med, Sabin Vaccine Inst, Houston, TX 77030 USA
[2] Baylor Coll Med, Natl Sch Trop Med, Texas Childrens Hosp, Ctr Vaccine Dev, Houston, TX 77030 USA
[3] Drugs Neglected Dis Initiat DNDi, Geneva, Switzerland
[4] Drugs Neglected Dis Initiat DNDi, Delhi, India
[5] FIND, Geneva, Switzerland
[6] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA
[7] Natl Inst Med Res, Dar Es Salaam, Tanzania
[8] Carlos Slim Fdn, Mexico City, DF, Mexico
[9] WHO Special Programme Res & Training Trop Dis TRD, World Bank, UNDP, UNICEF, Geneva, Switzerland
基金
比尔及梅琳达.盖茨基金会;
关键词
ECONOMIC VALUE; INSECTICIDE RESISTANCE; LEISHMANIASIS VACCINE; VECTOR COMPETENCE; HEALTH-POLICY; TSETSE-FLIES; DRUG; MOSQUITO; ERADICATION; CANDIDATES;
D O I
10.1371/journal.pntd.0003895
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Today, the World Health Organization recognizes 17 major parasitic and related infections as the neglected tropical diseases (NTDs). Despite recent gains in the understanding of the nature and prevalence of NTDs, as well as successes in recent scaled-up preventive chemotherapy strategies and other health interventions, the NTDs continue to rank among the world's greatest global health problems. For virtually all of the NTDs (including those slated for elimination under the auspices of a 2012 London Declaration for NTDs and a 2013 World Health Assembly resolution [WHA 66.12]), additional control mechanisms and tools are needed, including new NTD drugs, vaccines, diagnostics, and vector control agents and strategies. Elimination will not be possible without these new tools. Here we summarize some of the key challenges in translational science to develop and introduce these new technologies in order to ensure success in global NTD elimination efforts.
引用
收藏
页数:14
相关论文
共 87 条
[1]   Case study for a vaccine against leishmaniasis [J].
Alvar, Jorge ;
Croft, Simon L. ;
Kaye, Paul ;
Khamesipour, Ali ;
Sundar, Shyam ;
Reed, Steven G. .
VACCINE, 2013, 31 :B244-B249
[2]  
[Anonymous], 2014, Wkly Epidemiol Rec, V89, P61
[3]  
[Anonymous], 2013, IMPLEMENTATION RES H
[4]  
[Anonymous], 2015, AFR PROGR ONCH CONTR
[5]  
[Anonymous], 2013, WHO
[6]  
[Anonymous], 2012, WHO TECHN REP SER
[7]   The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas [J].
Bacon, Kristina M. ;
Hotez, Peter J. ;
Kruchten, Stephanie D. ;
Kamhawi, Shaden ;
Bottazzi, Maria Elena ;
Valenzuela, Jesus G. ;
Lee, Bruce Y. .
VACCINE, 2013, 31 (03) :480-486
[8]   A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance [J].
Balasegaram, Manica ;
Brechot, Christian ;
Farrar, Jeremy ;
Heymann, David ;
Ganguly, Nirmal ;
Khor, Martin ;
Levy, Yves ;
Matsoso, Precious ;
Ren Minghui ;
Pecoul, Bernard ;
Liu Peilong ;
Tanner, Marcel ;
Rottingen, John-Arne .
PLOS MEDICINE, 2015, 12 (05)
[9]   Control of Important Helminthic Infections: Vaccine Development as Part of the Solution [J].
Bergquist, Robert ;
Lustigman, Sara .
ADVANCES IN PARASITOLOGY, VOL 73: IMPORTANT HELMINTH INFECTIONS IN SOUTHEAST ASIA: DIVERSITY AND POTENTIAL FOR CONTROL AND ELIMINATION, PT B, 2010, 73 :297-326
[10]  
BIO Ventures for Global Health, 2015, GLOB HLTH PRIM